|
RBMS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.19250000002658E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.596700E-04 |
| Normal-vs-Stage2 |
2.342500E-02 |
| Normal-vs-Stage3 |
1.03269999995881E-06 |
| Normal-vs-Stage4 |
4.34600000431828E-09 |
| Stage1-vs-Stage2 |
8.998400E-01 |
| Stage1-vs-Stage3 |
1.511810E-02 |
| Stage1-vs-Stage4 |
3.376000E-04 |
| Stage2-vs-Stage3 |
1.417550E-01 |
| Stage2-vs-Stage4 |
7.741200E-03 |
| Stage3-vs-Stage4 |
1.118990E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.09649999999684E-05 |
| Normal-vs-AfricanAmerican |
5.781500E-04 |
| Normal-vs-Asian |
1.243890E-03 |
| Caucasian-vs-AfricanAmerican |
3.513800E-01 |
| Caucasian-vs-Asian |
7.853200E-01 |
| AfricanAmerican-vs-Asian |
4.742800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.960560E-04 |
| Normal-vs-Female |
4.90050000001574E-06 |
| Male-vs-Female |
9.329400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.581400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.81355999999688E-05 |
| Normal-vs-Age(61-80Yrs) |
4.64839999825273E-08 |
| Normal-vs-Age(81-100Yrs) |
1.173980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.765600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.444800E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.053600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.134000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.364400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.311000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.963880E-02 |
| Classical-VS-Follicular |
1.912180E-02 |
| Classical-VS-Other |
8.152400E-01 |
| Classical-VS-Normal |
1.616500E-03 |
| Tall-VS-Follicular |
4.089800E-01 |
| Tall-VS-Other |
1.706390E-01 |
| Tall-VS-Normal |
1.67024999999654E-05 |
| Follicular-VS-Other |
3.089400E-01 |
| Follicular-VS-Normal |
1.90382999999406E-05 |
| Other-VS-Normal |
5.268400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.85750000003537E-06 |
| Normal-vs-N1 |
2.19059999999605E-05 |
| N0-vs-N1 |
4.311000E-01 |
|
|
